Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Profile of COPD Patients Refusing Educational Program in Pulmonary Rehabilitation and Impact on the Benefits
NCT number | NCT04301245 |
Other study ID # | RETRO-ETP |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 28, 2020 |
Est. completion date | April 10, 2020 |
Verified date | May 2020 |
Source | ADIR Association |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Pulmonary rehabilitation (PR) has proven its efficacy to improve dyspnea, health status,
exercise tolerance and quality of life for patients with stable Chronic Obstructive Pulmonary
Disease (COPD). Exercise training has previously been thoroughly studied but education has
been less studied in PR. Furthermore, only few studies have investigated the added value of
an educational program (EP) to exercise training on clinical and physical factors.
Characterizing those patients who refuse EP is therefore a first step to better target them
and potentially improve their adherence and outcome following PR.
The aim of this study was to determine the characteristics of the COPD patients referred to
PR who refused EP compare to those who accepted and to identify the independent predictive
factors of refusal. The investigators also sought to compare the change in clinical outcomes
and number and length of hospitalization at six months following PR among those patients who
accepted or not to participate in EP.
Status | Completed |
Enrollment | 201 |
Est. completion date | April 10, 2020 |
Est. primary completion date | March 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of COPD, - >18 years old, - Stable state of COPD. Exclusion Criteria: - Patients who have not been offered an educational program - Patients who have already been offered an educational program during a pulmonary rehabilitation in the same center. |
Country | Name | City | State |
---|---|---|---|
France | ADIR Association | Bois-Guillaume |
Lead Sponsor | Collaborator |
---|---|
ADIR Association |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Multiple logistic regression between the variables defined and the refusal of educational program | The variables are described below in primary outcomes | Baseline | |
Primary | Gender | Gender will be analysed in logistic regression. | Baseline | |
Primary | Age | Age will be analysed in logistic regression. | Baseline | |
Primary | Height | Height will be analysed in logistic regression. | Baseline | |
Primary | Weight | Weight will be analysed in logistic regression. | Baseline | |
Primary | Body mass index | Body mass index will be analysed in logistic regression. | Baseline | |
Primary | COPD stages | COPD stages will be analysed in logistic regression. | Baseline | |
Primary | Forced Expiratory Volume in one second | Forced Expiratory Volume in one second will be analysed in logistic regression. | Baseline | |
Primary | Forced Vital Capacity | Forced Vital Capacity will be analysed in logistic regression. | Baseline | |
Primary | Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity | Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity will be analysed in logistic regression. | Baseline | |
Primary | Total Lung Capacity | Total Lung Capacity will be analysed in logistic regression. | Baseline | |
Primary | Residual Volume | Residual Volume will be analysed in logistic regression. | Baseline | |
Primary | Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume | Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume will be analysed in logistic regression. | Baseline | |
Primary | Comorbidities | Comorbidities will be analysed in logistic regression. | Baseline | |
Primary | Tabacco status | Tabacco status will be analysed in logistic regression. | Baseline | |
Primary | Tabacco consumption | Tabacco consumption will be analysed in logistic regression. | Baseline | |
Primary | Prescription of oxygen | Prescription of oxygen will be analysed in logistic regression. | Baseline | |
Primary | Prescription of non invasive ventilation | Prescription of non invasive ventilation will be analysed in logistic regression. | Baseline | |
Primary | Arterial oxygen partial pressure | Arterial oxygen partial pressure will be analysed in logistic regression. | Baseline | |
Primary | Arterial carbon dioxide partial pressure | Arterial carbone dioxide partial pressure will be analysed in logistic regression. | Baseline | |
Primary | Location of the training sessions | Location of the training sessions will be analysed in logistic regression. | Baseline | |
Primary | Ambulance transport | Number of patients with an ambulance transport will be analysed in logistic regression. | Baseline | |
Primary | Distance between patient's home and center | Distance between patient's home and center will be analysed in logistic regression. | Baseline | |
Primary | Dyspnea | Dyspnea assessed by the modified Medical Research Council scale will be analysed in logistic regression. | Baseline | |
Primary | 6-Minute Stepper Test | Number of steps during the 6-Minute Stepper Test will be analysed in logistic regression. | Baseline | |
Primary | 6-Minute Walk Test | Distance during the 6-Minute Walk Test will be analysed in logistic regression. | Baseline | |
Primary | Maximal oxygen consumption | Maximal oxygen consumption during cardiopulmonary exercise testing will be analysed in logistic regression. | Baseline | |
Primary | Maximal workload | Maximal workload achieved during cardiopulmonary exercise testing will be analysed in logistic regression. | Baseline | |
Primary | Saint George's Respiratory Questionnaire | Quality of life assessed by Saint George's Respiratory Questionnaire will be analysed in logistic regression. | Baseline | |
Primary | Employment | Employment will be analysed in logistic regression. | Baseline | |
Primary | Educational level | Educational level assessed by the international classification "Classification Internationale Type de l'Education" will be analysed in logistic regression. | Baseline | |
Primary | Cognitive impairment | Cognitive impairment assessed by the Montreal Cognitive Assessment will be analysed in logistic regression. | Baseline | |
Primary | Anxiety and depression level | Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression. | Baseline | |
Secondary | 6-Minute Stepper Test | Change in number of steps during the 6-Minute Stepper Test will be compared between groups. | 2 months | |
Secondary | 6-Minute Walk Test | Change in distance during the 6-Minute Walk Test will be compared between groups. | 2 months | |
Secondary | Saint George's Respiratory Questionnaire | Change in Saint George's Respiratory Questionnaire will be compared between groups. | 2 months | |
Secondary | Anxiety and depression level | Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression. | 2 months | |
Secondary | Cognitive impairment | Change in cognitive impairment assessed by the Montreal Cognitive Assessment will be compared between groups. | 2 months | |
Secondary | Number of hospitalizations | Number of hospitalizations will be compared between groups. | 6 months | |
Secondary | Number of hospitalized patients | Number of hospitalized patients will be compared between groups. | 6 months | |
Secondary | Number of days of hospitalization | Number of days of hospitalization will be compared between groups. | 6 months | |
Secondary | Attendance rate at educational sessions | Attendance rate at education sessions will be analysed | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|